Psychosocial and clinical predictors of response to pharmacotherapy for depression

Journal of Psychiatry and Neuroscience

Volumn 27, Issue 4, 2002, Pages 250-257

  Bagby, R Michael ^a   Ryder, Andrew G ^a   Cristi, Carolina ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Antidepressive agents; Behavioral symptoms; Comorbidity; Depressive disorder; Drug therapy; Psychiatric status rating scales; Psychology, social; Recurrence; Remission induction; Risk factors; Treatment outcome

Indexed keywords

CITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGORAPHOBIA; ANXIETY NEUROSIS; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DISEASE COURSE; DISEASE DURATION; DRUG EFFECT; DRUG EFFICACY; HUMAN; ONSET AGE; PANIC; PERSONALITY; PHYSICAL DISEASE; PREDICTION; QUALITY OF LIFE; RELIGION; REMISSION; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SUBSTANCE ABUSE; SYMPTOM; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; HUMANS; PERSONALITY DISORDERS; PSYCHOLOGY;

EID: 0036656201     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Temperament predicts clomipramine and desipramine response in major depression
2. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine
3. Impact of acute psychiatric inpatient treatment on major depression in late life and prediction of response
4. Personality and the prediction of long-term outcome of depression
5. Refractory depression: Prediction of non-response by clinical indicators
6. Factors associated with outcome in major depression: A 6-month prospective study
7. Remission onset and relapse in depression. An 18-month prospective study of course for 100 first admission patients
8. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis
9. Child and adolescent mood disorders - Experience with serotonin-based therapies
10. A double-blind, randomized, placebo-controlled trial of fluoxetine in child and adolescent with depression
11. Residual symptoms after partial remission: An important outcome in depression
12. Prediction of response of chronic depression to imipramine
13. Age of onset in chronic major depression: Relation to demographic and clinical variables, family history, and treatment response
14. Antidepressants in clinical practice: Limitations of assessment methods and drug response
15. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome
16. Severity at baseline and onset of improvement in depression: Meta analysis of imipramine and moclobemide versus placebo
17. The relationship of depression to medical illness in an older community, population
18. Depression in elderly hospitalized patients with mental illness
19. Prevalence of depression and its correlates in older adults
20. The prognosis of depression in the elderly
21. Factors associated with recovery from and relapse into major depressive disorder in the elderly
22. Impact of physical illness on quality of life and antidepressant response in geriatric major depression
23. Social support and the outcome of major depression
24. Marital support and remission of treated depression. A prospective pilot study of mothers of infants and toddlers
25. Should physicians prescribe prayer for health? Spiritual aspects of well being considered
26. Religious coping and depression among elderly, hospitalized medically ill men
27. Ethnic differences in intrinsic/extrinsic religious orientation and depression in the elderly
28. Religious motivation in the elderly: A French-Canadian replication and extension
29. Religion and older men in prison
30. Religiosity and remission of depression in medically ill older patients
31. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders
32. Anxious and nonanxious depression
33. The co-morbidity factor: Establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression
34. Follow-up and family study of anxious depression
35. The comorbidity of anxiety and depression in general medical patients: A longitudinal study
36. Anxiety syndromes as epiphenomena of primary major depression: Outcome and familial psychopathology
37. Anxious depression: Clinical, family history, and naturalistic outcome comparison with panic and major depressive disorder
38. Anxiety as a current major depression: An exploratory investigation
39. Simultaneous panic and depressive disorders: Response to antidepressant treatments
40. Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression
41. Efficacy of venlafaxine and predictors of response in a prospective open-label study of patients with treatment-resistant major depression
42. Substance abuse disorders: A psychiatric priority
43. Alcoholism and primary major depression: A family study approach to co-existing disorders
44. Prevalence of smoking among psychiatric outpatients
45. The self medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence
46. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment
47. Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Relationship with response to treatment
48. Depressions secondary to other psychiatric disorders and medical illnesses
49. A comparative evaluation of substance abuse treatment IV. The effect of co-morbid psychiatric diagnoses on amount of treatment, continuing care, and 1-year outcomes
50. Personality disorders and treatment response in bulimia nervosa
51. The implications of DSM-III personality disorders for patients with major depression
52. Personality disorder co-morbidity with major depression and response to fluoxetine treatment
53. The relationship of affective illness and personality disorders in psychiatric outpatients
54. Personality and response to tricyclic antidepressants in depressed patients
55. Personality traits and response to desipramine
56. Major depression and the five-factor model of personality
57. Differential pharmacological treatment response in high angry and low angry hostile depressed patients: A retrospective analysis
58. Rumination and distraction in major depression: Assessing response to pharmacological treatment
59. Self-criticism and dependency in depressed patients treated with cognitive therapy or pharmacotherapy
60. Anger attacks in unipolar depression. Part 1: Clinical correlates and response to fluoxetine treatment
61. Personality disorder co-morbidity with major depression and response to treatment with sertraline or citalopram
62. Diagnostic viability of the depressive personality disorder